These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18035959)

  • 1. Prevention of Type 2 diabetes: fact or fiction?
    Chiasson JL
    Expert Opin Pharmacother; 2007 Dec; 8(18):3147-58. PubMed ID: 18035959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of type 2 diabetes: what is the evidence?
    Chiasson JL; Brindisi MC; Rabasa-Lhoret R
    Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and surgical intervention for the prevention of diabetes.
    Chiasson JL
    Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():31-42. PubMed ID: 16820729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the prevention of type 2 diabetes].
    Schernthaner G
    Wien Klin Wochenschr; 2003 Nov; 115(21-22):745-57. PubMed ID: 14743578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is type-2 diabetes mellitus preventable?].
    Jermendy G
    Orv Hetil; 2003 Sep; 144(39):1909-17. PubMed ID: 14598569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is it possible to prevent type 2 diabetes?].
    Laville M
    Ann Endocrinol (Paris); 2003 Jun; 64(3 Suppl):S37-44. PubMed ID: 12910058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of type 2 diabetes mellitus: recent advances.
    Younis N; Soran H; Farook S
    QJM; 2004 Jul; 97(7):451-5. PubMed ID: 15208433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing type II diabetes mellitus.
    Prisant LM
    J Clin Pharmacol; 2004 Apr; 44(4):406-13. PubMed ID: 15051749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
    Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
    Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.
    Irons BK; Mazzolini TA; Greene RS
    Pharmacotherapy; 2004 Mar; 24(3):362-71. PubMed ID: 15040650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
    Chiasson JL; Gomis R; Hanefeld M; Josse RG; Karasik A; Laakso M
    Diabetes Care; 1998 Oct; 21(10):1720-5. PubMed ID: 9773737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
    Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.
    Torgerson JS; Hauptman J; Boldrin MN; Sjöström L
    Diabetes Care; 2004 Jan; 27(1):155-61. PubMed ID: 14693982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lifestyle intervention in patients with non-insulin-dependent diabetes mellitus and impaired glucose tolerance.
    Uusitupa MI
    Ann Med; 1996 Oct; 28(5):445-9. PubMed ID: 8949977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of metformin for diabetes prevention.
    Slama G
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S104-11. PubMed ID: 14502107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.